ClinicalTrials.Veeva

Menu

Cervical Cancer Screening Strategies

L

Lei Li

Status

Enrolling

Conditions

Cervical Cytology
Cancer Screening
Human Papillomavirus Infection
Cervical Intraepithelial Neoplasia
Cervical Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This study is to investigate retrospectively the results of cervical cytology and high-risk human papillomavirus in the past 20 years recorded in Peking Union Medical College Hospital. The histological findings after cervical cancer screening were reviewed. The diagnostic values of different screening strategies were compared based on the results of cervical histology. The primary endpoint is the diagnosis of grade 2 cervical intraepithelial neoplasia (CIN2) or more severe lesions (CIN2+). The secondary endpoints include following objectives: (1) the invasive procedures needed according to the screening results; (2) the diagnosis of vaginal and/or vulval intraepithelial neoplasia; (3) the persistence and recurrence of human papillomavirus infection; and (4) the cost-effectiveness of screening strategies for CIN2+.

Enrollment

10,000 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 18 years or older
  • With definite cervical histology after cervical cancer screening, ore with at least one screening test after first testing

Exclusion criteria

  • Not meeting all of the inclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Lei Li, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems